Novo Nordisk
Diane Lee currently serves as the Global Associate Value Strategy & Payer Engagement Director for Market Access Emerging Therapies at Novo Nordisk, a position held since August 2024. Prior to this role, Diane was a Senior Global Market Access Manager at ALK from October 2020 to August 2024 and held various positions at Lundbeck, including Global Market Access Manager and Global Pricing Analyst from June 2017 to October 2020. Diane's experience also includes a role as Pricing & Market Access Intern at Creativ-Ceutical, where responsibilities involved analyzing market environments and pricing strategies, as well as previous internships in regulatory affairs and pharmacy settings. Diane holds an MSc in Economic Evaluation and Market Access of Healthcare Products from Université Paris Dauphine - PSL and a Doctorate in Pharmaceutical Sciences (PharmD) from Université Paris Cité.
This person is not in any teams
Novo Nordisk
378 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.